Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Deutsche Bank Maintains Hold on Ballys, Lowers Price Target to $20

Deutsche Bank analyst Carlo Santarelli maintains Ballys (NYSE:BALY) with a Hold and lowers the price target from $23 to $20.

byBenzinga Newsdesk

February 14, 2023

1 minute read

Deutsche Bank analyst Carlo Santarelli maintains Ballys (NYSE:BALY) with a Hold and lowers the price target from $23 to $20.

Analyst Ratings

Where Intercontinental Exchange Stands With Analysts

By Benzinga Insights

Today, 12:03 PM

Within the last quarter, Intercontinental Exchange (NYSE:ICE) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

ICE

News

Regeneron Announced New U.S. Government Agreement to Purchase 1.4M Additional Doses of REGEN-COV Antibody Cocktail @$2,100/Dose

By Charles Gross

Today, 12:03 PM

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Department of Health and Human Services (HHS) and the Department of Defense (DOD) will purchase 1.4 million additional doses of REGEN-COV (casirivimab and imdevimab). The government will continue to provide REGEN-COV at no cost to patients.

REGN

Livewire To Acquire Majority Equity Stake In LA Cannabis Direct-To-Consumer Delivery Company

By Vuk Zdinjak

Today, 12:03 PM

LiveWire Ergogenics Inc. (OTCPK:LVVV) has entered into an agreement to acquire a majority equity stake in the Green Eagle Cannabis Delivery company in Los Angeles, California.

LVVV